Kimberly-Clark Announces Executive Leadership Appointments to Drive Growth
DALLAS, Nov. 19, 2026
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.

![]()
Kimberly-Clark Announces Executive Leadership Appointments to Drive Growth
PR Newswire
DALLAS, Nov. 19, 2026
Katie Devine Named Chief Growth & Innovation Officer
Brian Giroux to Rejoin as Chief Customer Officer
DALLAS, Nov. 19, 2026 /PRNewswire/ — Kimberly-Clark Corporation (NASDAQ: KMB) today announced two executive appointments to strengthen the company’s focus on growth, innovation and commercial execution. Katie Devine has been appointed Chief Growth & Innovation Officer, and Brian Giroux will rejoin Kimberly-Clark as Chief Customer Officer. Both executives will join the company’s Enterprise Leadership Team and report to Mike Hsu, Chairman and Chief Executive Officer of Kimberly-Clark.
As Chief Growth & Innovation Officer, Devine will unite category strategy and innovation in one centralized team to build a powerful growth engine for the new Kimberly-Clark. She will lead the company’s global growth organization, responsible for sector leadership, analytics and research & development. As Chief Customer Officer, Giroux will lead the company’s global commercial transformation and trade optimization agenda, ensuring excellence across revenue growth management optimization, total commercial spend optimization and sales excellence.
“I truly believe that Kimberly-Clark’s biggest growth opportunities are ahead of us, and we are building the organization to capture them,” said Hsu. “As a proven global leader who has deep experience across our consumer health categories and previously led several of our brands at Johnson & Johnson, Katie is uniquely suited for this role. With her appointment, we will enhance the capabilities we have built through Powering Care and accelerate our ability to translate consumer and scientific insight into category-shaping innovation and growth.”
Hsu continued, “Brian is a seasoned global sales leader who brings deep experience with our customers and other commercial stakeholders. As we build on our world-class commercial capabilities, we are confident that Brian will deepen our engagement with customers and strengthen execution globally.”
Devine brings more than 25 years of experience across consumer health, pharmaceuticals, corporate strategy and veterinary health, having led numerous category-expanding marketing and innovation initiatives in pain relief, allergy, digestive health, smoking cessation and skin health, among other categories. Most recently, she served as Global President of Mars Science & Diagnostics and led the science and R&D agenda across Mars Petcare. Previously, she held senior leadership roles at Johnson & Johnson, including Global President of Consumer Self Care and Group President, U.S. Cardiovascular Health & Infectious Diseases.
“Kimberly-Clark has an extraordinary portfolio, trusted brands and a deep commitment to science-backed innovation,” said Devine. “I know firsthand how these brands can lead and grow categories, and I am honored to join the company at this exciting moment to bring growth and innovation closer together and help deliver extraordinary care for billions of consumers every day.”
Giroux brings more than 35 years of sales leadership experience at consumer-packaged goods companies, with a track record of large-scale commercial transformation and working with major retailers, distributors, digital platforms and strategic customers. An expert in customer development, retail execution and promotional efficiency, Giroux previously spent more than a decade in leading roles at Kimberly-Clark, most recently as Vice President and General Manager, U.S. Customer Development. Before that, he spent 28 years at Kraft Foods Group, holding multiple leadership roles in sales management, strategy, operations and planning.
“From my time at Kimberly-Clark, I know the strength of its people and the power of the commercial engine the company has built,” said Giroux. “I look forward to helping further develop the global rigor needed to deliver seamless execution and stronger customer engagement around the world.”
In connection with Devine’s appointment, Craig Slavtcheff, Chief Research & Development Officer, will depart Kimberly-Clark following a thoughtful transition in January.
Hsu concluded, “We appreciate Craig’s leadership and his thoughtful counsel and commitment during our integration efforts. I wish him all the best in his future endeavors.”
About Kimberly-Clark
Kimberly-Clark (NASDAQ: KMB) is the preeminent global health and wellness leader, built to deliver extraordinary care. Our portfolio of iconic personal care and consumer health brands, including Huggies, Listerine, Cottonelle, Neutrogena, Depend, Tylenol, Kleenex, Johnson’s Baby, Kotex and Scott, serves consumers across every stage of life in more than 175 countries. We combine consumer-led innovation, leading brand-building and commercial capabilities, and a fast and agile operating model to raise the standard of care for billions of people around the world. We are committed to using sustainable practices designed to support a healthy planet, build strong communities, and enable our business to thrive for decades to come. The KMB stock is a large cap growth and value stock and core S&P 500 equity held by more than 400 Exchange Traded Funds. Kimberly-Clark is considered a Dividend Aristocrat, having paid a dividend for 92 consecutive years and increasing its dividend in each of the past 54 consecutive years. To keep up with the latest news and learn more about the company’s more than 150-year history, visit the Kimberly-Clark website.
Forward Looking Statements
Certain matters contained in this press release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and are based upon management’s expectations and beliefs concerning future events impacting Kimberly-Clark. There can be no assurance that these future events will occur as anticipated or that our results will be as estimated. Forward-looking statements speak only as of the date they were made, and we undertake no obligation to publicly update them. The assumptions used as a basis for the forward-looking statements include many estimates that, among other things, depend on many factors outside our control. The factors described under Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025, as updated by our Quarterly Reports on Form 10-Q, or in our other SEC filings, among others, could cause our future results to differ from those expressed in any forward-looking statements made by us or on our behalf. Other factors not presently known to us or that we presently consider immaterial could also affect our business operations and financial results.
[KMB-F] [KMB-C]
Contacts
Investor Relations:
Christopher Jakubik, CFA
KC.InvestorRelations@kcc.com
Media Relations:
Kyrsten Aspegren
media.relations@kcc.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/kimberly-clark-announces-executive-leadership-appointments-to-drive-growth-302944550.html
SOURCE Kimberly-Clark Corporation


